 |
Iobenguane I 131 |
|---|---|
| Trade Name | Azedra Ultratrace |
| Orphan Indication | Neuroendocrine tumors |
| USA Market Approval | USA |
| USA Designation Date | 2006-01-18 00:00:00 |
| Sponsor | Progenics Pharmaceuticals, Inc.;One World Trade Center., 47th Floor, Suite J;New York, New York, 10007 |
